The 340B ACCESS Act would change rules for the federal 340B drug discount program. It would set clearer limits on which patients and care qualify for discounted drugs, restrict which pharmacies may dispense them, and add requirements for hospitals and other participating health centers. It would also require more reporting and claims data, create a claims data clearinghouse, and set new audits and penalties. Health plans, insurers, and pharmacy benefit managers could not treat participating health centers and pharmacies differently because they use 340B drugs.
Some patients could qualify for limits on what they pay out of pocket for 340B drugs at participating hospitals. The limits would depend on income and apply to eligible patients; certain nonhospital health centers would also have to offer discounts when their federal funding rules require affordability help. The bill would also change which care and pharmacies qualify for 340B pricing. Most provisions would take effect one year after enactment, with some exceptions.
The bill text does not provide a total cost estimate. No publicly available information.
The bill states that the program’s purpose is to help health centers serving underserved or vulnerable communities increase access to affordable drugs and health services.
No publicly available information.